Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Arizona Grants $5M to Barrow for Clinical Trial of Ibogaine in TBI
- Inaugural Chair of Otolaryngology Joins College
- Steve Pressé appointed director of ASU’s Biodesign Center for Single Molecule Biophysics
- An Educational Milestone: 145 New Medical Students Welcomed to Medicine
- ASU students evaluate agentic AI nurse assist’s know-how
- Flinn Foundation increases funding, opportunities for bioscience research, entrepreneurship programs
- BIO International Convention Recap: Arizona’s Momentum on Display